FDA plans to develop guidance to help COVID-19 vaccine, drug and testing manufacturers adapt to emerging variants of the SARS-CoV-2 virus.
‘We need to be prepared’: FDA will draft guidance to work with vaccine, drug and testing companies on COVID-19 variants
